Insulin Shocks

Author:

White Joseph1,Corwin Nicholas1

Affiliation:

1. Case Western Reserve University

Abstract

Abstract Some of the news about insulin is shocking. In the United States, people have died because they were rationing a life-saving medication discovered in the 1920s. How could this happen? Perhaps a better question is why anyone should be surprised. The insulin story both illustrates and challenges many understandings of the problems with insurance, treatment, payment, and politics in the US health care system. It particularly highlights consequences of structuring price discounts as rebates to health plans or government instead of as lower individual prices to patients. Perversely, this encourages higher list prices, which, for patients without insurance or with high cost sharing, make insulin less affordable than it would be without the rebates.

Publisher

Duke University Press

Subject

Health Policy

Reference95 articles.

1. ADA (American Diabetes Association). 2018. “Insulin Affordability Survey, 2018.” May22. http://main.diabetes.org/dorg/PDFs/2018-insulin-affordability-survey.pdf.

2. ADA (American Diabetes Association). 2019. “The History of a Wonderful Thing We Call Insulin.” July1. https://www.diabetes.org/blog/history-wonderful-thing-we-call-insulin.

3. Adler Loren , GinsburgPaul B., and LiebermanSteven M. 2019. “Understanding the Bipartisan Senate Finance Prescription Drug Reform Package.” USC-Brookings Schaeffer Initiative for Health Policy, October3. https://www.brookings.edu/blog/usc-brookings-schaeffer-on-health-policy/2019/10/03/understanding-the-bipartisan-senate-finance-prescription-drug-reform-package/.

4. Alston Maggie , DieguezGabriela, and TomickiSamantha. 2018. “A Primer on Prescription Drug Rebates: Insights into Why Rebates Are a Target for Reducing Prices.” Milliman, May21. https://www.milliman.com/en/insight/a-primer-on-prescription-drug-rebates-insights-into-why-rebates-are-a-target-for-reducing.

5. American Hospital Association. 2021. “Fact Sheet: The 340B Drug Pricing Program.” March. https://www.aha.org/system/files/media/file/2019/03/fact-sheet-340b-drug-pricinig-program-0119.pdf.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3